The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1382-1385

  Baghurst, Peter A ^a,b   Rodbard, David ^c   Cameron, Fergus J ^d  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Biomedical Informatics Consultants LLC   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Continuous glucose monitoring; Continuous overlapping net glycemic action; Glucose profiles; Glycemic variability; Mean amplitude of glycemic excursion; Standard deviation; Statistical experimental design

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ARTICLE; BLOOD; CHILD; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; METHODOLOGY; MONITORING; PREDICTIVE VALUE; PRESCHOOL CHILD; TIME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 79952998106     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400612     Document Type: Article

References (12)

1. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707-8.
2. Kilpatrick ES, Rigby AS, Atkin SL. For debate - after Ceriello Glucose variability and diabetes complication risk: we need to know the answer. Diabet Med. Epub ahead of print.
3. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.
4. Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care. 2009;32:1901-3.
5. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab. 2008;34(6 Pt 1):612-6.
6. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther. 2005;7(2):253-63.
7. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644-55.
8. Baghurst P. Calculating the mean amplitude of glycemic excursion (MAGE) from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther. 2010. (Forthcoming.)
9. Cameron FJ, Donath SM, Baghurst PA. Measuring glycaemic variation. Curr Diabetes Rev. 2010;6(1):17-26.
10. Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288-98.
11. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia. 2009;52(10):2229-32.
12. Rodbard D. New approaches to display of self-monitoring of blood glucose data. J Diabetes Sci Technol. 2009;3(5):1121-7.